Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
501
-
502
-
503
-
504
-
505
The point mutants E559A, E563A and K567A display altered DNA-binding kinetics.
Published 2014“…(D) Mutation of either glutamic acid 559 or 563 to alanines results in decreased dissociation rates from DNA and high-affinity GAS binding. …”
-
506
-
507
-
508
-
509
Changes associated with kidney fibrosis and effects of MN705 treatment on TGF-
Published 2025Subjects: -
510
Delphinidin alters VEGF-A splicing to increase VEGF-A<sub>165</sub>b and decrease total VEGF-A expression.
Published 2019“…<b>C)</b> Under both NG and HG condition, delphinidin significantly decreased the protein expression of total VEGF-A<sub>165</sub> (*p<0.05; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs). …”
-
511
-
512
-
513
-
514
-
515
HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression.
Published 2015“…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”
-
516
Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis.
Published 2025Subjects: -
517
-
518
-
519
Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF-
Published 2025Subjects: -
520